Dauntless Investment Group, LLC

Q4 2025 13F Holdings Report, Stock Holdings

Signature - Title
Matthew Okkerse - CFO
Location
Milford, MI
Holdings as of
31 Dec 2025
Value $
$25,069,925
Num holdings
53
Filing time
17 Feb 2026, 16:09:12 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included JOE, AGRO, LINC, AEON, and JBS. Confidential Treatment Requested (one or more holding(s) omitted).
Previous filing
Q3 2025 - 14 Nov 2025
SEC
View on sec.gov
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2025 Q4 compared to 2025 Q3 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Confidential Treatment Requested. (The Manager has omitted from this public Form 13F one or more holding(s) for which it is requesting confidential treatment from the U.S. Securities and Exchange Commission pursuant to section 13(f) of the Exchange Act and rule 24b-2 thereunder)

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Matthew Okkerse CFO Milford, Michigan 17 Feb 2026

The information included on the Information Table with respect to the holdings of AEON Biopharma, Inc. ("AEON") and Femasys Inc. ("FEMY") reflect the exercise of Pre-funded Warrants held by Dauntless Investment Group, LLC ("DIG") after giving effect to provisions that prevent the exercise of such securities if the beneficial ownership of such entity would exceed 9.99% of the underlying security following such exercise. As of December 31, 2025, DIG held an aggregate of 2,131,852 Common Shares of AEON and 5,931,890 Common Shares of FEMY.